We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Automated Decapping System Replaces Manual Steps

By LabMedica International staff writers
Posted on 17 Jan 2012
Print article
Image: The Decapper unit automates initial steps of sample processing, decapping, and aliquotting (Photo courtesy of Qiagen).
Image: The Decapper unit automates initial steps of sample processing, decapping, and aliquotting (Photo courtesy of Qiagen).
An open platform system enables laboratories to automate many tedious manual steps required for unscrewing (or “decapping”) the lids of clinical sample vials, extracting the sample material, and pipetting it into testing vials and then recapping the clinical sample vial.

The QIAensemble Decapper improves laboratory workflow by providing an automated solution for transferring clinical samples from closed primary vials to compatible tubes for downstream processing

Qiagen N.V. (Hilden, Germany) launched the QIAensemble Decapper automation system that will facilitate the handling of liquid-based cytology and various other types of liquid samples that are processed by clinical laboratories around the world.

Considered the first instrument of its kind designed to support downstream molecular testing, the QIAensemble Decapper will help to reduce the risk for injuries to laboratory staff from repetitive motions, while also eliminating the risk for variation among laboratory staff and improving productivity.

A professional ergonomics evaluation of the sample preparation processing of 88 samples showed QIAensemble Decapper reduced hands-on time by 70% compared to the time required for manual processing by a laboratory worker while eliminating more than 1,200 movements.

With a capacity to process up to approximately 800 samples per shift (excluding set-up time and post-processing requirements), QIAensemble Decapper was designed specifically for the handling and transfer of sample materials, and the addition of reagents. The instrument accommodates a variety of fluid types of variable viscosity for both samples and reagents.

The software system, which is operated by an intuitive graphical user interface (GUI), provides laboratory staff with a comprehensive and user-friendly report for each run. The software also offers chain of custody and an ability to identify samples that were not properly transferred.

The Decapper standardizes the processing with digital data collection and is highly flexible with regard to output tube types, such as conical tubes, u-shaped tubes, BD Vacutainer tubes, and Greiner’s Vacuette tubes. Additionally, the instrument will be compatible with sample racks on the QIAsymphony SP automation system.

Related Links:
Qiagen


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The utilization of liquid biopsies in cancer research is a rapidly developing field (Photo courtesy of Lightspring/Shutterstock)

Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis

B-cell lymphoma is the predominant form of cancer affecting the lymphatic system, with about 30% of patients with aggressive forms of this disease experiencing relapse. Currently, the disease’s risk assessment... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Sampler device could revolutionize sample collection for diagnostic tests (Photo courtesy of ReadyGo Diagnostics)

First of Its Kind Universal Tool to Revolutionize Sample Collection for Diagnostic Tests

The COVID pandemic has dramatically reshaped the perception of diagnostics. Post the pandemic, a groundbreaking device that combines sample collection and processing into a single, easy-to-use disposable... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.